Omega Fund Management »

Engene Holdings shares owned by Omega Fund Management

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 1.1M 9.23

More positions owned by Omega Fund Management

Lexeo Therapeutics Common Stock (LXEO)
Replimune Group Common Stock (REPL)
Nuvation Bio Common Stock Class A (NUVB)
enGene Holdings Common Stock (ENGN)
Morphic Holding Common Stock (MORF)
Spruce Biosciences Common Stock (SPRB)
Kronos Bio Common Stock (KRON)
Ikena Oncology Common Stock (IKNA)
Sana Biotechnology Common Stock (SANA)
Theseus Pharmaceuticals Common Stock
Immunic Common Stock (IMUX)
Syros Pharmaceuticals Common Stock (SYRS)
enGene Holdings Warrant (ENGNW)
Senti Biosciences Common Stock (SNTI)

View all positions for Omega Fund Management

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
BVF
Blue Owl Capital Holdings
Omega Fund Management
Vivo Capital
Polar Securities
Royal Bank of Canada
Goldman Sachs Group
Citadel Advisors
UBS Group

View all funds holding Engene Holdings